| Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract (NCT05297760) | University of Zurich | 2022-02-10 |
| Airway Immune Response to Allergens (Use Lay Language Here) (NCT04619017) | JOSALYN CHO | 2021-10-28 |
| Andosan in Allergic and Asthma Patients (NCT05192720) | University Hospital, Akershus | 2021-08-31 |
| Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma (NCT05008965) | Oneness Biotech Co., Ltd. | 2021-07-27 |
| Efficacy of Face Mask in Reducing Respiratory Allergic Symptoms in Birch-allergic Subjects in ALYATEC Exposure Chamber (NCT06267261) | Alyatec | 2021-06-07 |
| A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3) (NCT04699604) | Bridgette Jones | 2021-04-28 |
| Environmental Pollutants and Their Effects on Respiratory Allergy (NCT04902989) | Cindy Elizabeth de Lira-Quezada | 2021-03-10 |
| Effectiveness and Safety of Omalizumab in Children With Allergic Asthma. (NCT05424523) | Novartis Pharmaceuticals | 2021-02-25 |
| Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma (NCT05813470) | Cinnagen | 2021-01-18 |
| Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients (NCT04673591) | T-Balance Therapeutics GmbH | 2020-12-09 |
| abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies (NCT04442932) | Abionic SA | 2020-11-15 |
| Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses (NCT04648813) | University of Saskatchewan | 2020-11-13 |
| Tyrosine Allergoid Paediatric and Adult Study (NCT05186025) | Allergy Therapeutics | 2020-11-06 |
| Analytical Validation of the abioSCOPE Device With an IgE Test Panel: Point-of-Care Precision, Sample Type Comparison and Method Correlation (NCT04401631) | Abionic SA | 2020-11-01 |
| Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma (NCT04542902) | Lithuanian University of Health Sciences | 2020-10-01 |
| Anti-inflammatory Effects Glycopyrronium (NCT04259164) | University Medical Center Groningen | 2020-09-10 |
| Gender Differences and SNPs in Asthmatic Patients (NCT04567212) | University of Catanzaro | 2020-08-01 |
| Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels (NCT04389034) | Allergy Therapeutics | 2020-04-22 |
| Towards Targeting the ORigin of the Inflammatory Cascade in Allergic Asthma (NCT04264377) | University Medical Center Groningen | 2020-02-07 |
| Documentation of Efficacy of Intralymphatic Allergen Immunotherapy (NCT05191186) | Aarhus University Hospital | 2020-02-01 |
| Immune Response Features in Allergic Airway Diseases (NCT04352088) | Lithuanian University of Health Sciences | 2019-05-01 |
| Impact of Pollution on Allergic Rhinitis and Sleep Quality: the POLLAR Study (NCT03776773) | University Hospital, Grenoble | 2019-04-08 |
| Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest (NCT03820154) | Prof. Dr. Claus Bachert BVBA | 2019-03-01 |
| Intervention in Chronic Pediatric Patients and Their Families. (NCT04476433) | University of Valencia | 2019-02-04 |
| Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients (NCT03850626) | Leti Pharma GmbH | 2018-09-09 |
| Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment (NCT03431961) | Gail Gauvreau | 2018-03-07 |
| Children's Respiratory and Environmental Workgroup (NCT03213184) | University of Wisconsin, Madison | 2017-12-26 |
| House Dust Mite Induced Inflammasome Activation on Corticosteroid Resistance (NCT03307278) | China Medical University Hospital | 2017-11-30 |
| Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma (NCT03388359) | Lithuanian University of Health Sciences | 2017-06-01 |
| Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma (NCT04678063) | Alyatec | 2017-04-10 |
| Pemirolast in Allergen Challenge (PEMAG) (NCT03119714) | Karolinska University Hospital | 2016-11-01 |
| Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure (NCT02911688) | University of North Carolina, Chapel Hill | 2016-09-01 |
| Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Mite Allergic Subjects With Asthma (NCT04663880) | Alyatec | 2016-08-30 |
| To Identify Persons Who Are Susceptible to WSP-induced Inflammation and Examine the Role of GSTM1 and Other Factors in This Susceptibility (NCT02767973) | University of North Carolina, Chapel Hill | 2016-05-01 |
| Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic Rhinitis (NCT02908360) | Nantes University Hospital | 2015-07-10 |
| Bronchial Allergen Provocation Tests in Asthmatics in Guangzhou (NCT02504528) | Guangzhou Institute of Respiratory Disease | 2015-07-01 |
| Specific Immunotherapy for Allergic Child (NCT02965612) | Mariella Enoc | 2015-05-01 |
| Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations (NCT03861910) | Federico II University | 2014-12-01 |
| Eosinophil Induced Remodelling in Asthma (NCT02648074) | Lithuanian University of Health Sciences | 2014-03-01 |
| Analysis of Fel d 1-specific T Cells After Airway Allergen Challenge in Asthma (NCT01612715) | Hamilton Health Sciences Corporation | 2014-01-29 |
| Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study) (NCT02096237) | Fresenius Medical Care Deutschland GmbH | 2013-12-01 |
| The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases (NCT02214303) | Lithuanian University of Health Sciences | 2013-04-01 |
| Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract (NCT01821716) | Laboratorios Leti, S.L. | 2013-03-01 |
| Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils (NCT02023151) | Johns Hopkins University | 2013-02-01 |
| A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma (NCT01703312) | Novartis Pharmaceuticals | 2012-11-01 |
| Change in Airway Responsiveness After Allergen Exposure (NCT01699594) | University of Saskatchewan | 2012-10-01 |
| The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy (NCT01776177) | Joseph D. Diaz, MD | 2012-09-01 |
| A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL (NCT01544348) | MedImmune LLC | 2012-01-01 |
| Cobra (Severe Asthma)Medical-economic (NCT01669681) | University Hospital, Montpellier | 2011-12-20 |
| Characterization of the Role of Histamine in Children With Asthma (NCT01392859) | Children's Mercy Hospital Kansas City | 2011-06-01 |
| The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Children (NCT01144910) | Johann Wolfgang Goethe University Hospital | 2011-05-01 |
| Asthma Inflammation Research (NCT01536522) | The Cleveland Clinic | 2011-01-01 |
| Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma (NCT01976208) | Shanghai Zhangjiang Biotechnology Limited Company | 2010-12-01 |
| Induction of Allergen Specific Bronchial Immunotolerance After Specific Immunotherapy (NCT01479205) | Johann Wolfgang Goethe University Hospital | 2010-07-01 |
| Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years) (NCT01155700) | Novartis Pharmaceuticals | 2010-06-01 |
| A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy (NCT01125748) | Genentech, Inc. | 2010-05-01 |
| 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma (NCT01353755) | Allergopharma GmbH & Co. KG | 2009-10-01 |
| Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma (NCT00980707) | Associated Scientists to Help Minimize Allergies | 2009-08-01 |
| Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing (NCT00813748) | Genentech, Inc. | 2009-03-01 |
| A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma (NCT00781443) | Genentech, Inc. | 2008-12-01 |
| Effect of Montelukast on Basophils, In-vitro (NCT00710450) | Creighton University | 2008-05-01 |
| Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists (NCT00670930) | Novartis Pharmaceuticals | 2008-04-01 |
| The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis (NCT01318954) | Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. | 2008-01-01 |
| Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract (NCT00622362) | Laboratorios Leti, S.L. | 2008-01-01 |
| Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma (NCT00550797) | Syntara | 2008-01-01 |
| Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI (NCT00565591) | Respirics Inc. | 2007-11-01 |
| A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma (NCT00434434) | Genentech, Inc. | 2007-10-01 |
| Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma (NCT00485576) | Alexion Pharmaceuticals, Inc. | 2007-09-01 |
| Safety and Repeatability of Bronchial Challenge With Grass-pollen (NCT00507039) | Johann Wolfgang Goethe University Hospital | 2007-02-01 |
| Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics (NCT00581048) | Vanderbilt University | 2006-12-01 |
| A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma (NCT00406965) | Genentech, Inc. | 2006-12-01 |
| Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma (NCT00492076) | ALK-Abelló A/S | 2006-10-01 |
| Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis (NCT00396409) | Novartis Pharmaceuticals | 2006-02-01 |
| A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy (NCT00283504) | Children's Hospital of The King's Daughters | 2006-01-01 |
| Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics (NCT00535431) | Aerovance, Inc. | 2005-12-01 |
| Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma (NCT00267202) | Novartis | 2005-12-01 |
| Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children (NCT00515775) | Technische Universität Dresden | 2005-09-01 |
| Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma (NCT00736801) | University of Rostock | 2005-09-01 |
| Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy (NCT00652223) | Cytos Biotechnology AG | 2005-03-01 |
| A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study) (NCT00535028) | Aerovance, Inc. | 2005-01-01 |
| Fish Oil and Asthma in House Dust Mite Allergy (NCT00380926) | Johann Wolfgang Goethe University Hospital | 2004-04-01 |
| Effect of Xolair on Airway Hyperresponsiveness (NCT00208234) | Creighton University | 2004-01-01 |
| The Effect of Salmeterol on Eosinophil (EOS) Function (NCT00214019) | University of Wisconsin, Madison | 2003-11-01 |
| Prevention of Asthma and Allergy by Probiotic Lactobacillus GG (NCT00490425) | Johann Wolfgang Goethe University Hospital | 2002-10-01 |
| Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma (NCT00829179) | Duke University | 2002-10-01 |
| Role of Indoor Pollutants on House Dust Mite Allergic Asthma (NCT01019291) | University Hospital, Strasbourg, France | |